EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

GP60 and SPARC as albumin receptors: key targeted sites for the delivery of antitumor drugs

Qingzhi Ji, Huimin Zhu, Yuting Qin, Ruiya Zhang, Lei Wang, Erhao Zhang, Xiaorong Zhou, Run Meng

Frontiers in Pharmacology · 23.01.2024 · 15

DOI: 10.3389/fphar.2024.1329636 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 23.01.2024. Verfasst von Qingzhi Ji und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Yancheng Teachers University, Yancheng, China. Die Arbeit wurde bisher 137-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Albumin is derived from human or animal blood, and its ability to bind to a large number of endogenous or exogenous biomolecules makes it an ideal drug carrier. As a result, albumin-based drug delivery systems are increasingly being studied. With these in mind, detailed studies of the transport mechanism of albumin-based drug carriers are particularly important. As albumin receptors, glycoprotein 60 (GP60) and secreted protein acidic and rich in cysteine (SPARC) play a crucial role in the delivery of albumin-based drug carriers. GP60 is expressed on vascular endothelial cells and enables albumin to cross the vascular endothelial cell layer, and SPARC is overexpressed in many types of tumor cells, while it is minimally expressed in normal tissue cells. Thus, this review supplements existing articles by detailing the research history and specific biological functions of GP60 or SPARC and research advances in the delivery of antitumor drugs using albumin as a carrier. Meanwhile, the deficiencies and future perspectives in the study of the interaction of albumin with GP60 and SPARC are also pointed out.

Schlagwörter

Stichwörter der Autor:innen

GP60SPARCalbumindrug carrierstarget delivery

Autor:innen und Institutionen

  • School of Pharmacy, Yancheng Teachers University, Yancheng, China.
  • Sheyang County Comprehensive Inspection and Testing Center, Yancheng, China.
  • Department of Immunology, Medical School, Nantong University, Nantong, China.

Zitieren

APA

Ji, Q., Zhu, H., Qin, Y., Zhang, R., Wang, L., Zhang, E., Zhou, X., & Meng, R. (2024). GP60 and SPARC as albumin receptors: key targeted sites for the delivery of antitumor drugs. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1329636

Vancouver

Ji Q, Zhu H, Qin Y, Zhang R, Wang L, Zhang E, et al. GP60 and SPARC as albumin receptors: key targeted sites for the delivery of antitumor drugs. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1329636

BibTeX
@article{Ji2024,
  author = {Ji, Qingzhi and Zhu, Huimin and Qin, Yuting and Zhang, Ruiya and Wang, Lei and Zhang, Erhao and Zhou, Xiaorong and Meng, Run},
  title = {GP60 and SPARC as albumin receptors: key targeted sites for the delivery of antitumor drugs},
  journal = {Frontiers in Pharmacology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fphar.2024.1329636}
}
Kostenlos starten →